Form D · Private Equity Fund

OrbiMed Asia Partners VI, L.P.

New York, NY · CIK 0002087034

Offering snapshot reported Oct 16, 2026 · SEC filing

Reported sold: $1.05B
Investors reported: 72
Minimum accepted: $0
First sale: Sep 30, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$533,984,000 → $1,045,599,648
Reported investors45 → 72

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 16, 2026	Amendment	$1,045,599,648	$511,615,648vs May 28, 2026	72	SEC filing
May 28, 2026	Amendment	$533,984,000	No comparison	45	SEC filing
Sep 29, 2025	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0 (estimated)
Finders' fees: $0 (estimated)
Form D file number: 021-559156

The total amount sold includes capital committed by the General Partner.

Paid based on a percentage of committed capital of investors introduced by selling agent. Management fees will be offset by any such amounts paid by the Issuer. Such amounts do not reduce the offering proceeds available for investment.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
UBS Switzerland AG	None
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED	7691
J.P. Morgan Securities LLC	79

Source: Form D, filed Oct 16, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ORBIMED ASIA PARTNERS VI, LP

Investment adviser: ORBIMED ADVISORS LLC

Gross asset value: $685M
Beneficial owners: 77
ADV minimum commitment: $1M

Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV (CAYMAN ) LTD. GEORGE TOWN, Cayman Islands Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP NEW YORK, New York, United States

Custodian AFRAASIA BANK LIMITED PORT LOUIS, Mauritius Related to adviser: No

Custodian ICICI BANK LIMITED MUMBAI, India Related to adviser: No

Custodian JP MORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Marketer J.P. MORGAN SECURITIES LLC NEW YORK, New York, United States Related to adviser: No

Marketer MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No

Marketer UBS SWITZERLAND AG ZURICH, Switzerland Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LLP
PCAOB 185

JP MORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE9

J.P. MORGAN SECURITIES LLC
CRD 79 · SEC 801-3702

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
CRD 7691 · SEC 801-14235

Filing source

Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-3808027086

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Sven H. Borho	Director
Carl L. Gordon	Director
W. Carter Neild	Director
N/A Orbi Med Advisors Vi Limited	Executive
N/A Orbi Med Asia Gp Vi, L.P.	Executive
Sunny Sharma	Director
David G. Wang	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

601 Lexington Avenue 54 Th Floor
New York, NY, 10022